Article Text
Abstract
This personal narrative tugs at the heart strings. However, personal narratives are not sufficient to justify public funding for any screening policy. We have to take seriously the ‘just caring’ problem. We have only limited resources to meet virtually unlimited health care needs. No doubt, screening tests often save lives. The author wants public funding for prostate-specific antigen screening for prostate cancer. However, why only prostate cancer? Numerous cancers at various stages can be screened for. Are all of them equally deserving of public funding? What about screening for a very long list of other life-threatening medical disorders? There is nothing ethically special about cancer. Where does the money come from to pay for all these screening tests? Do we reduce expensive life-prolonging care for patients in late-stage diseases? Ultimately, a balance must be struck between saving statistical lives through screening and saving identifiable lives in the intensive care unit. Achieving a just balance requires rational democratic deliberation as justification for these choices, not personal narratives.
- justice
- genetic screening
- cancer
- statistical lives
- democratic deliberation
Statistics from Altmetric.com
Footnotes
Contributors I am the sole author of this essay.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; internally peer reviewed.
Linked Articles
Read the full text or download the PDF:
Other content recommended for you
- Care of men with cancer-predisposing BRCA variants
- Is one narrative enough? Analytical tools should match the problems they address
- A Community Jury on PSA screening: what do well-informed men want the government to do about prostate cancer screening—a qualitative analysis
- Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline
- Arrogance of ‘but all you need is a good index finger’: A narrative ethics exploration of lack of universal funding of PSA screening in Canada
- Primary goals, information-giving and men’s understanding: a qualitative study of Australian and UK doctors’ varied communication about PSA screening
- Prostate cancer risk assessment model: a scoring model based on the Swedish Family-Cancer Database
- Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis
- Screening for prostate cancer remains controversial
- Prostate screening could rise again after new US cancer data